Table 2.
Group | n | Triglyceride (mg/dL) | Cholesterol (mg/dL) | NEFA (mmol/L) | Glucose (mg/dL) |
---|---|---|---|---|---|
N | 12 | 186.8 ± 11.7 a | 194.7 ± 20.3 c | 0.64 ± 0.03 d | 102.6 ± 4.8 a |
S | 12 | 224.2 ± 10.9 bc | 227.1 ± 36.0 a | 0.95 ± 0.05 a | 50.1 ± 5.2 c |
L | 12 | 196.0 ± 6.6 c | 222.9 ± 15.5 b | 0.92 ± 0.01 a | 50.6 ± 4.9 c |
M | 12 | 197.3 ± 23.9 c | 222.1 ± 24.2 a | 0.85 ± 0.01 a | 72.7 ± 16.4 b |
H | 12 | 188.7 ± 21.4 d | 207.1 ± 13.8 c | 0.83 ± 0.01 b | 64.5 ± 2.1 b |
P | 12 | 186.4 ± 7.6 a | 202.9 ± 22.2 b | 0.79 ± 0.01 c | 101.4 ± 9.4 a |
Values not sharing letters in the same vertical column differ significantly from one another by one-way ANOVA and Duncan’s Multiple Range Test (p < 0.05) among six groups. N: Normal group, S: Sepsis group (i.p. LPS), L: Sepsis group with low-dose WBG, M: Sepsis group with moderate-dose WBG, H: Sepsis group with high-dose WBG, P: Positive control group (i.p. PDTC).